{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:45:41Z","timestamp":1791027941574,"version":"4.1.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Inflammatory bowel disease (IBD) is an increasingly prevalent condition in developed countries. Alongside the growing number of patients, there is a rising incidence of disease-related complications, including osteoporosis. While well-established risk factors for low bone mineral density in IBD\u2014such as low body mass or steroid therapy\u2014are widely recognized, other contributing factors warrant further investigation. One such factor is visfatin, a proinflammatory adipokine encoded by the <jats:italic>NAMPT<\/jats:italic> gene.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This review aimed to explore the association between visfatin level, bone health, and obesity among patients with inflammatory bowel disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key findings<\/jats:title><jats:p>Although visfatin is primarily associated with metabolic syndrome, it may also influence bone mineral density by affecting osteoblast and osteoclast differentiation and function. Additionally, some studies have identified a correlation between visfatin levels and bone mineral density. A deeper understanding of visfatin\u2019s role in osteoporosis development may contribute to the identification of novel therapeutic strategies. Therefore, lower bone mineral density in inflammatory bowel disease may be associated with obesity and visfatin levels. However, visfatin concentrations depend on many factors, including genetics, immunology, and nutritional factors, which may affect visfatin levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Implications<\/jats:title><jats:p>Current research highlights visfatin as both a potential biomarker and a therapeutic target for osteoporosis treatment. Nevertheless, limited studies have specifically examined the relationship between visfatin and bone mineral density in IBD. Further research is required to clarify this association and to explore how variations in visfatin levels impact bone density in IBD patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1533955","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T07:10:01Z","timestamp":1742281801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Relationship of visfatin with obesity and osteoporosis in patients with inflammatory bowel disease: a narrative review"],"prefix":"10.3389","volume":"16","author":[{"given":"Alicja Ewa","family":"Ratajczak-Paw\u0142owska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Szymczak-Tomczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Hryhorowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Skoracka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Rychter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Skrzypczak-Zieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"S\u0142omski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Dobrowolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Krela-Ka\u017amierczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2022.11.023","article-title":"Role of adipokines (omentin and visfatin) in coronary artery disease","volume":"33","author":"Ali","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i30.10840","article-title":"Role of visfatin in obesity-induced insulin resistance","volume":"10","author":"Abdalla","year":"2022","journal-title":"World J Clin cases"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.11.003","article-title":"Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity","volume":"91","author":"Esteghamati","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"B4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40200-016-0275-1","article-title":"Mechanisms involved in altered bone metabolism in diabetes: a narrative review","volume":"15","author":"Ghodsi","year":"2016","journal-title":"J Diabetes Metab Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0474","article-title":"A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly","volume":"94","author":"Sucunza","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/MEG.0000000000000617","article-title":"Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease","volume":"28","author":"Terzoudis","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-019-01206-6","article-title":"The influence of visfatin, RBP-4 and insulin resistance on bone mineral density in women with treated primary osteoporosis","volume":"31","author":"Mihai","year":"2019","journal-title":"Aging Clin Exp Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2007.08.012","article-title":"Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in chinese men","volume":"387","author":"Peng","year":"2008","journal-title":"Clin Chim Acta"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346674","article-title":"Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal chinese women","volume":"33","author":"Zhang","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052713","article-title":"Bone fragility in gastrointestinal disorders","volume":"23","author":"Merlotti","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1346.055","article-title":"The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with crohn\u2019s disease","volume":"1068","author":"Pazianas","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i46.6156","article-title":"Basic and clinical aspects of osteoporosis in inflammatory bowel disease","volume":"13","author":"Rodr\u00edguez-Bores","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.amjmed.2009.01.022","article-title":"Osteoporosis in inflammatory bowel disease","volume":"122","author":"Ali","year":"2009","journal-title":"Am J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20931","article-title":"Effects of infliximab therapy on abdominal fat and metabolic profile in patients with crohn\u2019s disease","volume":"15","author":"Parmentier-Decrucq","year":"2009","journal-title":"Inflammation Bowel Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000527","article-title":"Visceral adipose tissue in patients with crohn\u2019s disease correlates with disease activity, inflammatory markers, and outcome","volume":"21","author":"B\u00fcning","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/nu10091192","article-title":"Obesity in inflammatory bowel disease: Gains in adiposity despite high prevalence of myopenia and osteopenia","volume":"10","author":"Bryant","year":"2018","journal-title":"Nutrients"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/nu15173824","article-title":"Nutrition, nutritional status, micronutrients deficiency, and disease course of inflammatory bowel disease","volume":"15","author":"Valvano","year":"2023","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.181","article-title":"Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes","volume":"14","author":"Singh","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1038393","article-title":"Multiple sclerosis and obesity: The role of adipokines","volume":"13","author":"Correale","year":"2022","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2023.10.013","article-title":"The effect of overweight or obesity on osteoporosis: A systematic review and meta-analysis","volume":"42","author":"Liu","year":"2023","journal-title":"Clin Nutr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.14.2.1431-1437.1994","article-title":"Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor","volume":"14","author":"Samal","year":"1994","journal-title":"Mol Cell Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.2047-6310.2013.00149.x","article-title":"Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children","volume":"9","author":"Ooi","year":"2014","journal-title":"Pediatr Obes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/01.RES.0000173298.38808.27","article-title":"Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation","volume":"97","author":"van der Veer","year":"2005","journal-title":"Circ Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0807581","article-title":"Pre-B cell colony-enhancing factor (PBEF)\/visfatin: a novel mediator of innate immunity","volume":"83","author":"Luk","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.11.003","article-title":"Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epithelium","volume":"193","author":"Ognjanovic","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/JB.183.4.1168-1174.2001","article-title":"Identification of a plasmid-encoded gene from haemophilus ducreyi which confers NAD independence","volume":"183","author":"Martin","year":"2001","journal-title":"J Bacteriol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2007.01.009","article-title":"Effects of genetic variation in the visfatin gene (PBEF1) on obesity, glucose metabolism, and blood pressure in children","volume":"56","author":"K\u00f6rner","year":"2007","journal-title":"Metabolism"},{"key":"B30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/1735-1995.193177","article-title":"Genetic associations of the visfatin G-948T polymorphism with obesity-related metabolic traits in an iranian population","volume":"21","author":"Javanmard","year":"2016","journal-title":"J Res Med Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2005.06.010","article-title":"Visfatin: the missing link between intra-abdominal obesity and diabetes","volume":"11","author":"Sethi","year":"2005","journal-title":"Trends Mol Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/07853890902729760","article-title":"Overexpression of visfatin\/PBEF\/Nampt alters whole-body insulin sensitivity and lipid profile in rats","volume":"41","author":"Sun","year":"2009","journal-title":"Ann Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00318.2009","article-title":"Skeletal muscle NAMPT is induced by exercise in humans","volume":"298","author":"Costford","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00113.2006","article-title":"Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise","volume":"292","author":"Frydelund-Larsen","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B35","article-title":"Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery","volume":"61","author":"Kukla","year":"2010","journal-title":"Pol J Pathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.665893","article-title":"Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization","volume":"115","author":"Dahl","year":"2007","journal-title":"Circulation"},{"key":"B37","article-title":"Visfatin expression and genetic polymorphism in patients with traumatic brain injury","volume":"8","author":"Xiao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1159\/000443433","article-title":"Chronic administration of visfatin ameliorated diabetic nephropathy in type 2 diabetic mice","volume":"41","author":"Kang","year":"2016","journal-title":"Kidney Blood Press Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0173-z","article-title":"Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin","volume":"49","author":"Curat","year":"2006","journal-title":"Diabetologia"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1201","article-title":"Visfatin in overweight\/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review","volume":"27","author":"Chang","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12657","article-title":"Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1","volume":"19","author":"Chen","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.01.032","article-title":"Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin","volume":"184","author":"Xia","year":"2014","journal-title":"Am J Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155193","article-title":"The up-regulation of markers of adipose tissue fibrosis by visfatin in pre-adipocytes as well as obese children and adolescents","volume":"134","author":"Ezzati-Mobaser","year":"2020","journal-title":"Cytokine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202203_28360","article-title":"Asprosin, visfatin and subfatin as new biomarkers of obesity and metabolic syndrome","author":"Ugur","year":""},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnme.2013.02.001","article-title":"Increased serum visfatin levels in obesity and its association with anthropometric\/biochemical parameters, physical inactivity and nutrition","volume":"8","author":"Jurdana","year":"2013","journal-title":"e-SPEN J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2006.12.001","article-title":"Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus","volume":"56","author":"Takebayashi","year":"2007","journal-title":"Metab - Clin Exp"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2021.1874997","article-title":"Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis","volume":"127","author":"Jiang","year":"2021","journal-title":"Arch Physiol Biochem"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1475","article-title":"Elevated plasma level of Visfatin\/Pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2174\/1566524018666180705114131","article-title":"Adipokine visfatin\u2019s role in pathogenesis of diabesity and related metabolic derangements","volume":"18","author":"Kumari","year":"2018","journal-title":"Curr Mol Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1303","article-title":"Human visfatin expression: Relationship to insulin sensitivity, intramyocellular lipids, and inflammation","volume":"92","author":"Varma","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e39613","DOI":"10.1097\/MD.0000000000039613","article-title":"Association of circulating visfatin level and metabolic fatty liver disease: An updated meta-analysis and systematic review","volume":"103","author":"Chen","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10143029","article-title":"Serum visfatin levels in nonalcoholic fatty liver disease and liver fibrosis: Systematic review and meta-analysis","volume":"10","author":"Ismaiel","year":"2021","journal-title":"J Clin Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating Properties1","volume":"178","author":"Moschen","year":"2007","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1906","article-title":"Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner","volume":"15","author":"Van Gool","year":"2009","journal-title":"Nat Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.939","article-title":"Involvement of dimethylarginine dimethylaminohydrolase-2 in visfatin-enhanced angiogenic function of endothelial cells","volume":"25","author":"Xiao","year":"2009","journal-title":"Diabetes\/Metabolism Res Rev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-1220","article-title":"Obesity and thyroid cancer risk among U.S. men and women: A pooled analysis of five prospective studies","volume":"20","author":"Kitahara","year":"2011","journal-title":"Cancer Epidemiology Biomarkers Prev"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.02.012","article-title":"Circulating levels of novel adipocytokines in patients with colorectal cancer","volume":"62","author":"Fazeli","year":"2013","journal-title":"Cytokine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24248","article-title":"Visfatin induces stromal cell-derived factor-1 expression by \u03b21 integrin signaling in colorectal cancer cells","volume":"228","author":"Huang","year":"2013","journal-title":"J Cell Physiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604363","article-title":"Expression of SDF-1\u03b1 and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer","volume":"98","author":"Yoshitake","year":"2008","journal-title":"Br J Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.04.076","article-title":"Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells","volume":"345","author":"Dieudonne","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.2175","article-title":"Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: An in vitro study","volume":"29","author":"Bu\u0142dak","year":"2013","journal-title":"Oncol Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081178","article-title":"Visfatin connection: Present and future in osteoarthritis and osteoporosis","volume":"8","author":"Franco-Trepat","year":"2019","journal-title":"J Clin Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-006-0155-7","article-title":"Insulin-like effects of visfatin on human osteoblasts","volume":"80","author":"Xie","year":"2007","journal-title":"Calcified Tissue Int"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114508048307","article-title":"Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats","volume":"101","author":"P\u00e9rez-Echarri","year":"2008","journal-title":"Br J Nutr"},{"key":"B65","article-title":"Effects of fatty acid regulation on visfatin gene expression in adipocytes","volume":"119","author":"Wen","year":"2006","journal-title":"Chin (Engl)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114518002726","article-title":"A diet high in sugar-sweetened beverage and low in fruits and vegetables is associated with adiposity and a pro-inflammatory adipokine profile","volume":"120","author":"Koebnick","year":"2018","journal-title":"Br J Nutr"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1159\/000350066","article-title":"The effect of sodium restricted diet on plasma visfatin levels in hypertensive patients with visceral obesity","volume":"37","author":"Rotkegel","year":"2013","journal-title":"KBR"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.950900","article-title":"Mid- and long-term changes in satiety-related hormones, lipid and glucose metabolism, and inflammation after a mediterranean diet intervention with the goal of losing weight: A randomized, clinical trial","volume":"9","author":"Hernando-Redondo","year":"2022","journal-title":"Front Nutr"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2008.01.052","article-title":"Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients","volume":"24","author":"de Luis","year":"2008","journal-title":"Nutrition"},{"key":"B70","article-title":"Lack of effect of a moderate hypocaloric diet on visfatin levels in morbid obese patients: relationship with insulin resistance","volume":"14","author":"De Luis","year":"2010","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1080\/09637486.2019.1658723","article-title":"Effects of a dietary intervention with mediterranean and vegetarian diets on hormones that influence energy balance: results from the CARDIVEG study","volume":"71","author":"Dinu","year":"2020","journal-title":"Int J Food Sci Nutr"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173995","article-title":"Does a vegetarian diet affect the levels of myokine and adipokine in prepubertal children","volume":"10","author":"Ambroszkiewicz","year":"2021","journal-title":"J Clin Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2013.07.012","article-title":"Effect of the mediterranean diet on plasma adipokine concentrations in men with metabolic syndrome","volume":"62","author":"Richard","year":"2013","journal-title":"Metabolism"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/750860","article-title":"Early effects of a hypocaloric, mediterranean diet on laboratory parameters in obese individuals","volume":"2014","author":"Greco","year":"2014","journal-title":"Mediators Inflammation"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2014.1","article-title":"Comparative effect of two mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes","volume":"68","author":"Lasa","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"B76","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbadis.2018.10.020","article-title":"The role of obesity in inflammatory bowel disease","volume":"1865","author":"Kreuter","year":"2019","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4806-5","article-title":"Association between adipokines levels with inflammatory bowel disease (IBD): Systematic reviews","volume":"62","author":"Morshedzadeh","year":"2017","journal-title":"Dig Dis Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.15403\/jgld-3504","article-title":"Serum visfatin as a diagnostic marker of active inflammatory bowel disease","volume":"30","author":"Saadoun","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.3892\/etm.2018.5835","article-title":"Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control study","volume":"15","author":"Trejo-Vazquez","year":"2018","journal-title":"Exp Ther Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21901","article-title":"Serum visfatin levels in ulcerative colitis","volume":"30","author":"Dogan","year":"2015","journal-title":"J Clin Lab Anal"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i22.6912","article-title":"Serum adipokines in inflammatory bowel disease","volume":"20","author":"Waluga","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310705","article-title":"Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate crohn\u2019s disease from UC","volume":"66","author":"Starr","year":"2017","journal-title":"Gut"},{"key":"B84","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mrfmmm.2009.06.012","article-title":"Pre-B cell colony enhancing factor\/NAMPT\/visfatin and its role in inflammation-related bone disease","volume":"690","author":"Moschen","year":"2010","journal-title":"Mutat Research\/Fundamental Mol Mech Mutagenesis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2020.101086","article-title":"Vitamin D suppresses proangiogenic factors in patients with ulcerative colitis: A randomized double blind placebo controlled clinical trial","volume":"39","author":"Emami","year":"2020","journal-title":"Complementary Therapies Clin Pract"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/life12020272","article-title":"Body composition as a modulator of bone health changes in patients with inflammatory bowel disease","volume":"12","author":"Soare","year":"2022","journal-title":"Life"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.7326\/AITC201708010","article-title":"Osteoporosis","volume":"167","author":"Ensrud","year":"2017","journal-title":"Ann Intern Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1660790","article-title":"Osteoporosis: Current concepts","volume":"6","author":"Akkawi","year":"2018","journal-title":"Joints"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2018.06.001","article-title":"Visfatin alters the cytokine and matrix-degrading enzyme profile during osteogenic and adipogenic MSC differentiation","volume":"26","author":"Tsiklauri","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"key":"B91","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrrheum.2016.49","article-title":"Adipokines in bone disease","volume":"12","author":"Neumann","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1024860","article-title":"Association of serum levels of visfatin, intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females","volume":"13","author":"Tariq","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00774-015-0728-5","article-title":"Visfatin is a positive predictor of bone mineral density in young survivors of acute lymphocytic leukemia","volume":"35","author":"Siviero-Miachon","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346703","article-title":"Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome","volume":"34","author":"Iacobellis","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2010.01905.x","article-title":"Adipocytokines and bone mineral density in adolescent female athletes","volume":"99","author":"Gruodyt\u0117","year":"2010","journal-title":"Acta Paediatrica"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0047","article-title":"Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis","volume":"96","author":"Biver","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.yexcr.2017.01.021","article-title":"Nicotinamide phosphoribosyltransferase (Nampt) may serve as the marker for osteoblast differentiation of bone marrow-derived mesenchymal stem cells","volume":"352","author":"He","year":"2017","journal-title":"Exp Cell Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/895045","article-title":"Novel adipokines and bone metabolism","volume":"2013","author":"Liu","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13578-017-0154-6","article-title":"Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase","volume":"7","author":"Ling","year":"2017","journal-title":"Cell Bioscience"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072277","article-title":"At the crossroads of the adipocyte and osteoclast differentiation programs: Future therapeutic perspectives","volume":"21","author":"Muruganandan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.6069","article-title":"Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-\u03baB ligand-induced osteoclast differentiation in vitro","volume":"15","author":"Baek","year":"2017","journal-title":"Mol Med Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182970","article-title":"Effects of short-term dry immersion on bone remodeling markers, insulin and adipokines","volume":"12","author":"Linossier","year":"2017","journal-title":"PloS One"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.116","article-title":"NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis","volume":"49","author":"Park","year":"2017","journal-title":"Exp Mol Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121500","article-title":"Visfatin enhances RANKL-induced osteoclastogenesis In vitro: Synergistic interactions and its role as a mediator in osteoclas differentiation and activation","volume":"14","author":"Ok","year":"2024","journal-title":"Biomolecules"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1533955\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T07:10:08Z","timestamp":1742281808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1533955\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":104,"alternative-id":["10.3389\/fimmu.2025.1533955"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1533955","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"article-number":"1533955"}}